How to Calculate Carotid Stenosis Using the NASCET Method

May 29, 2026

Overview

The NASCET (North American Symptomatic Carotid Endarterectomy Trial) method is the internationally accepted standard for quantifying internal carotid artery (ICA) stenosis. It uses two angiographic diameter measurements to produce a percentage that directly correlates with clinical trial evidence for treatment thresholds.

This guide walks through the full calculation process. Use the NASCET Calculator to automate the math and generate severity classifications.

This guide is for trained clinicians. The calculator and content are educational resources — treatment decisions require full clinical assessment.

Step 1 — Obtain Adequate Imaging

NASCET % can be calculated from:

Digital Subtraction Angiography (DSA) — gold standard; direct luminal measurement
CT Angiography (CTA) — ≥64-slice; accurate with proper MPR/axial reformats
MR Angiography (CE-MRA) — gadolinium-enhanced preferred; TOF can over/underestimate

Image quality requirements:

Adequate contrast opacification of the ICA lumen distal to the stenosis
No significant motion artifact at the measurement point
Slice thickness ≤1 mm for CTA

Duplex ultrasound does not directly measure NASCET % — it measures flow velocities. Velocity criteria (e.g., PSV >230 cm/s ≈ ≥70% NASCET) are validated correlates, but the actual formula requires direct diameter measurement from cross-sectional imaging.

Step 2 — Identify the Stenosis Location

The culprit lesion is typically at the carotid bifurcation or the proximal internal carotid artery (ICA), 1–3 cm above the common carotid bifurcation. On your imaging:

Identify the carotid bifurcation
Trace the ICA proximally from the bifurcation
Locate the point of maximum narrowing — this is where you will measure d_s
Trace the ICA distally past the stenosis to the straight segment — this is where you will measure d_d

Step 3 — Measure d_s: Stenosis Diameter

At the point of maximum narrowing:

Measure the residual lumen from inner wall to inner wall
Orient the measurement perpendicular to the vessel axis at that point
Include only the contrast-filled lumen — do not include the vessel wall or plaque
Use the projection that shows the minimum diameter (for DSA: rotate as needed)

Record d_s in millimeters. Typical values for significant stenosis range from 0.5–3.0 mm.

Step 4 — Measure d_d: Distal ICA Reference Diameter

Moving distally from the stenosis:

Skip past any post-stenotic dilatation (immediately distal to the stenosis, the ICA often widens transiently due to turbulent flow)
Identify a segment where vessel walls are parallel and straight
This is typically 1–2 cm distal to the stenotic segment, in the mid-cervical ICA
Measure lumen diameter inner wall to inner wall

Record d_d in millimeters. Typical distal ICA diameters: 3.5–6.0 mm in adults.

For detailed placement guidance and common measurement errors, see the NASCET Measurement Technique Reference.

Step 5 — Apply the NASCET Formula

NASCET % = (1 − d_s / d_d) × 100

Worked Example:

d_s = 1.8 mm (stenosis residual lumen)
d_d = 5.5 mm (distal ICA reference)

NASCET % = (1 − 1.8 / 5.5) × 100
         = (1 − 0.327) × 100
         = 67.3% → Moderate Stenosis

Step 6 — Interpret the Severity Category

NASCET %	Category	Clinical Context
0–49%	Mild	Surgical benefit not demonstrated
50–69%	Moderate	Moderate benefit in symptomatic patients
70–99%	Severe	Strong CEA benefit for symptomatic (NNT≈6)
Near-occlusion	Severe/special	Individualized assessment required
100%	Occlusion	CEA not applicable

Step 7 — Apply Clinical Trial Evidence

Symptomatic patients (TIA or stroke within 6 months, ipsilateral to stenosis):

NASCET %	NASCET Trial Evidence
≥70%	CEA reduces 2-year ipsilateral stroke risk from 26% to 9% (absolute risk reduction 17%, NNT ≈ 6)
50–69%	Moderate absolute risk reduction (~6.5% over 5 years); CEA beneficial in selected patients
<50%	No demonstrable benefit from CEA over medical therapy

Asymptomatic patients (ACAS trial, 1995):

Stenosis ≥60%: CEA reduces 5-year ipsilateral stroke risk from 11% to 5.1% (ARR 5.9%, NNT ≈ 17) in low-surgical-risk patients
The benefit is smaller and more debated than in symptomatic patients
Medical therapy has improved substantially since ACAS (1995); some guidelines now favor medical management for asymptomatic patients

Step 8 — Document and Report

Standard reporting elements for carotid stenosis:

Imaging modality used (DSA/CTA/MRA)
Measurement method (NASCET or ECST — specify)
d_s and d_d values in mm
Calculated NASCET %
Severity category
Side (right or left ICA)
Symptomatic or asymptomatic status

Note: Always report the measurement method. A “70% stenosis” without specifying NASCET vs ECST is ambiguous — the same lesion measures 70% by NASCET and approximately 82% by ECST.

Summary Checklist

Step	Action	Status
1	Obtain CTA, MRA, or DSA with adequate ICA opacification	□
2	Identify point of maximum narrowing	□
3	Measure d_s perpendicular to vessel axis, inner wall to inner wall	□
4	Measure d_d in disease-free, straight distal ICA	□
5	Apply: NASCET % = (1 − d_s/d_d) × 100	□
6	Classify: Mild / Moderate / Severe	□
7	Apply symptom status + trial thresholds	□
8	Document method, values, and category	□

Use the NASCET Calculator to complete steps 5–6 automatically and receive a formatted clinical summary with ECST equivalent and treatment context.

For CEA vs CAS evidence once classification is complete, see CEA vs Carotid Artery Stenting. For medical therapy that applies regardless of intervention decision, see Carotid Stenosis Medical Management.